| Entry |
|
|---|
| Name |
Tosufloxacin tosylate hydrate (JP18);
Tosufloxacin tosilate;
Ozex (TN);
Tosuxacin (TN) |
|---|
| Formula |
C19H15F3N4O3. C7H8O3S. H2O
|
|---|
| Exact mass |
594.1396
|
|---|
| Mol weight |
594.56
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG01217): | D01996<JP> |
|
|---|
| Efficacy |
Antibacterial, Nucleic acid biosynthesis inhibitor |
|---|
| Comment |
Fluoroquinolones
|
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA22 Tosufloxacin
D01996 Tosufloxacin tosylate hydrate (JP18) <JP>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AE Fluoroquinolones
S01AE09 Tosufloxacin
D01996 Tosufloxacin tosylate hydrate (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D01996 Tosufloxacin tosylate hydrate (JP18)
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
624 Synthetic antibacterials
6241 Pyridonecarboxylic acids
D01996 Tosufloxacin tosylate hydrate (JP18)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG01217 Tosufloxacin
D01996 Tosufloxacin tosylate hydrate
Drug classes [BR:br08332]
Antibacterial
DG01549 Fluoroquinolone
D01996 Tosufloxacin tosylate hydrate
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D01996 Tosufloxacin tosylate hydrate (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01996 Tosufloxacin tosilate hydrate
D01996 Tosufloxacin tosilate tablets
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG01217 Tosufloxacin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
DG01217 Tosufloxacin
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 41
1 C8y C 18.4652 -14.7295
2 N4y N 19.6754 -15.4278
3 C8y C 18.4652 -13.3329
4 N5x N 17.2548 -15.4278
5 C8y C 19.6755 -16.8243
6 C8x C 20.8859 -14.7295
7 C8y C 19.6290 -12.6346
8 C8x C 17.2548 -12.6346
9 C8y C 16.0444 -14.7295
10 C8y C 20.8860 -17.5227
11 C8x C 18.4652 -17.5227
12 C8y C 20.8859 -13.3329
13 O5x O 19.6290 -11.2380
14 C8y C 16.0444 -13.3329
15 N1y N 14.8340 -15.4742
16 C8x C 20.8860 -18.9657
17 X F 22.0963 -16.8243
18 C8x C 18.4652 -18.9193
19 C6a C 22.0497 -12.6346
20 X F 14.8340 -12.6346
21 C8y C 19.6755 -19.6174
22 O6a O 23.2601 -13.3329
23 O6a O 22.0497 -11.2380
24 X F 19.6755 -21.0605
25 C1x C 13.5475 -14.9442
26 C1x C 12.6459 -16.0041
27 C1y C 13.3752 -17.1890
28 C1x C 14.8208 -16.8616
29 N1a N 12.8271 -18.4910
30 C8y C 26.9981 -15.7899
31 C8x C 25.7805 -16.4924
32 C8x C 28.2156 -16.4924
33 S4a S 26.9980 -14.4316
34 C8x C 25.7805 -17.8973
35 C8x C 28.2156 -17.8973
36 O1d O 25.5931 -14.4316
37 O1d O 28.4029 -14.4316
38 O1d O 26.9980 -13.0736
39 C8y C 26.9981 -18.6465
40 C1a C 26.9981 -20.0046
41 O0 O 31.5933 -16.1000
BOND 43
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 2
10 5 11 1
11 6 12 2
12 7 13 2
13 8 14 2
14 9 15 1
15 10 16 1
16 10 17 1
17 11 18 2
18 12 19 1
19 14 20 1
20 16 21 2
21 19 22 1
22 19 23 2
23 21 24 1
24 7 12 1
25 9 14 1
26 18 21 1
27 15 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 15 28 1
32 27 29 1
33 30 31 1
34 30 32 2
35 30 33 1
36 31 34 2
37 32 35 1
38 33 36 2
39 33 37 2
40 33 38 1
41 34 39 1
42 39 40 1
43 35 39 2
|
|---|
